PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Seed infusion strongly reduced the severity of collagen-induced arthritis in mice, reducing synovial pannus and leukocyte infiltration [PMID:15083889].
Ethanolic extract from fruits demonstrated antinociceptive effects on mechanical and thermal hyperalgesia in mice with partial sciatic nerve ligation [PMID:26386380].
Oleaginous seed extracts showed acute and topic anti-edematogenic activity in carrageenan-induced paw edema and croton oil-induced ear edema [PMID:14980011].
Hexane extract from seeds showed in vitro activity against several oral bacteria and three mycobacterial strains [PMID:38143320].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38169762 (2023) — Complete Chloroplast Genomes of Pterodon emarginatus Vogel and Pterodon pubescens Benth: Comparative and Phylogenetic Analyses. · Current genomics
- 2.PMID: 15083889 (2004) — Immunomodulatory effects of sucupira (Pterodon pubescens) seed infusion on collagen-induced arthritis. · Clinical and experimental rheumatology
- 3.PMID: 26613051 (2015) — Sucupira as a Potential Plant for Arthritis Treatment and Other Diseases. · Arthritis
- 4.PMID: 36518414 (2022) — Lecithin-based nanocapsule loading sucupira (Pterodon emarginatus) oil effects in experimental mucositis. · Toxicology reports
- 5.PMID: 32041134 (2020) — Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.